Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.

Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.

Item
http://www.wikidata.org/entity/Q38024011
The σ2 receptor: a novel protein for the imaging and treatment of cancer.Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapyHaem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistanceTetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity.Sigma receptors [σRs]: biology in normal and diseased statesInterrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Radiosynthesis and in vivo evaluation of a novel σ1 selective PET ligand.EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy.Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
P2860

Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.

Item
http://www.wikidata.org/entity/Q38024011
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.
@en
type
label
Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.
@en
prefLabel
Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.
@en
P2093
P2860
P304
P31
P356
10.1016/J.SURG.2012.05.014
P407
P433
P478
P577
P698
P932